Dorothy Clarke
General Counsel
Ernexa Therapeutics Inc. (ERNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ERNA alertsAbout Dorothy Clarke
Dorothy Clarke is recorded as General Counsel at Ernexa Therapeutics Inc. (ERNA). The newest filing on record that lists Dorothy Clarke as General Counsel at Ernexa Therapeutics Inc. (ERNA) is dated October 7, 2024. Ernexa Therapeutics Inc. reported in an 8-K filed January 10, 2025 that Dorothy Clarke resigned as Board of Directors, effective January 6, 2025. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.
“On January 3, 2025, Dorothy Clarke submitted her resignation from the Board of Directors (the “Board”) of the Company, effective at 11:59 p.m. Eastern Time on January 6, 2025.”
Affiliation history
-
Current
Start not stated–present
Last confirmed October 7, 2024
-
Start not stated–2025-01-06
Company network
Leadership on record at Ernexa Therapeutics Inc.
- Dr. Matthew Angel CEO
- Matt Angel, Ph.D. CEO
- Sanjeev Luther CEO, Board Member
- Allen Wolff Chairman, Board Member
- James Bristol Chairman
- Luba Greenwood Chairman, Board Member
- Sandra Gurrola CFO
- Brant C. Binder Board Member
- Dennis H. Langer Board Member
- Dorothy J. Clarke Board Member